Vivanza Biosciences Ltd share price logo

Vivanza Biosciences Ltd Share Price (530057)

Check the latest share price of Vivanza Biosciences Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.

₹2.352.49%

as on 04:01PM, 13 Jun 2025

BSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Vivanza Biosciences Ltd Stock Performance

Get live Vivanza Biosciences Ltd share price, day's high and low, historical returns, and market stats.

  • Day's Low

    Day's High

    ₹2.32
    Day's Price Range
    ₹2.41
  • 52 Week's Low

    52 Week's High

    ₹1.9
    52-Week Price Range
    ₹6.15
1 Month Return+ 13.4 %
3 Month Return+ 12.32 %
1 Year Return-60.57 %
3 Year Return-87.85 %
5 Year Return+ 89.6 %
Previous Close₹2.41
Open₹2.36
Volume33.31K
Upper Circuit₹2.53
Lower Circuit₹2.29

Vivanza Biosciences Ltd Fundamentals & Key Indicators

Check Vivanza Biosciences Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹6.24 Cr

Return on Equity (ROE)

0

PE Ratio (TTM)

0

Return on capital employed (ROCE)

0

Industry PE ratio

57.39

Beta (LTM)

0.32

P/B Ratio

-0.04

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

143.9

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

1.16

Technical Analysis

How to invest in Vivanza Biosciences Ltd?

Investing in Vivanza Biosciences Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Vivanza Biosciences Ltd or 530057 on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Vivanza Biosciences Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Vivanza Biosciences Ltd with just a few clicks!

Vivanza Biosciences Ltd Stock's Interest Amongst Investors

114%

Period Jun 14, 2025 to May 15, 2025. Change in 30 Days vs previous period

Search interest for Vivanza Biosciences Ltd Stock has increased by 114% in the last 30 days, reflecting an upward trend in search activity.

Vivanza Biosciences Ltd Valuation

Track how Vivanza Biosciences Ltd P/E has moved over time to understand its valuation trends.

Vivanza Biosciences Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-15423.93x)

December 21, 2022

Today (-13.94x)

June 13, 2025

Industry (57.39x)

June 13, 2025

Highest (884.71x)

July 19, 2023

LowHigh

Today’s Price to Earnings Ratio: -13.94x

Vivanza Biosciences Ltd Financial Results

Get the annual and quarterly financial summary of Vivanza Biosciences Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25
Revenue

(in ₹ Cr)

4 (0%)2 (45%)3 (23%)2 (50%)0 (68%)
Net Income

(in ₹ Cr)

-0 (0%)0 (166%)0 (93%)0 (100%)-1 (2600%)
Net Profit Margin-9.28% (0%)11.07% (219%)0.67% (94%)2.67% (299%)-208.33% (7903%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

8 (0%)14 (79%)20 (44%)17 (17%)
Total Liabilities

(in ₹ Cr)

5 (0%)10 (128%)16 (55%)12 (24%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

3 (0%)-3 (210%)-1 (78%)0 (124%)2 (1012%)

Vivanza Biosciences Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Vivanza Biosciences Ltd.

  • Vivanza Biosciences Ltd Earnings Results

    Vivanza Biosciences Ltd’s net profit fell -143.9% since last year same period to ₹-1Cr in the Q4 2024-2025. On a quarterly growth basis, Vivanza Biosciences Ltd has generated -2600% fall in its net profits since last 3-months.

    Read More about Earnings Results

Vivanza Biosciences Ltd Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Vivanza Biosciences Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
20.02%
0.00
Foreign Institutions
0%
0.00
Mutual Funds
0%
0.00
Retail Investors
79.98%
0.00
Others
0%
0.00

Vivanza Biosciences Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Vivanza Biosciences Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA6.245.19%5.69NANA
NA81.5858.65%0.51140
NA1,949.0625.81%0.5158630
NA69.916.88%0.78245
NA375.2830.71%0.51NANA

Vivanza Biosciences Ltd News & Key Events

Latest news and events in one place to help you make informed investing decisions in Vivanza Biosciences Ltd.

  • Vivanza Biosciences Reports Significant Losses - 13 May, 2025

    Vivanza Biosciences reported a consolidated net loss of Rs 1.00 crore for Q1 March 2025, with sales plummeting 89.14% to Rs 0.48 crore. For the full year, the company faced a net loss of Rs 0.67 crore, down from a profit of Rs 0.55 crore the previous year, as annual sales declined 73.35% to Rs 7.42 crore.

Insights on Vivanza Biosciences Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 20.02% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 79.98% of holdings in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, Vivanza Biosci. stock has moved down by -60.6%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 0.04 Cr → -1.0 Cr (in ₹), with an average decrease of 2600.0% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 3.0 Cr → 0.53 Cr (in ₹), with an average decrease of 57.3% per quarter

About Vivanza Biosciences Ltd

Ivee Injectaa, a public limited company incorporated in March 1982 is engaged in large-volume parenteral drug manufacturing with an installed capacity of 18 lac pa in Sabalpur, Gujarat. Recently, it has completed an expansion and diversification program to increase the production to 54 lac pa with an additional small-volume parenteral manufacturing capacity of 294 lac pa. To fund the expansion, a public issue of 2170000 equity shares of Rs 10 each was released, aggregating Rs 217 lac. As one of the few companies with facilities for both glass and plastic containers, Ivee Injectaa was awarded a rate contract from the Government of Gujarat to supply its products for one year. Amidst the difficult business conditions in 19992000 due to recessionary trends, the company continues to strive for overall improvement in working.

Revenue: ₹0.48Cr as on March 2025 (Q4 FY25)
Net Profit: ₹-1.00Cr as on March 2025 (Q4 FY25)
OrganisationVivanza Biosciences Ltd
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs

What is Vivanza Biosciences Ltd share price today?

Vivanza Biosciences Ltd share price today stands at ₹2.35, Open: ₹2.36, Previous Close: ₹2.41, High: ₹2.41, Low: ₹2.32, 52 Week High: ₹6.15, 52 Week Low: ₹1.9.

What is today's traded volume of Vivanza Biosciences Ltd?

Today's traded volume of Vivanza Biosciences Ltd is 33.31K. Which means that 33.31K shares of Vivanza Biosciences Ltd were bought and sold on the stock market during today's trading session.

What is Vivanza Biosciences Ltd's market cap today?

Today's market capitalisation of Vivanza Biosciences Ltd is ₹9.48 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Vivanza Biosciences Ltd?

Vivanza Biosciences Ltd’s 52 week high is ₹6.15 and 52 week low is ₹1.9. The current share price of Vivanza Biosciences Ltd is ₹2.35, which is -61.79% down from its 52 week high and 23.68% up from its 52 week low.